Biological pacing has been proposed as a physiologic counterpart to electronic pacing, and the sinoatrial node (SAN) is the general standard for biological pacemakers. We tested the expression of SAN pacemaker cell activity when implanted autologously in the right ventricle (RV). We induced complete heart block and implanted electronic pacemakers in the RV of adult mongrel dogs. Autologous SAN cells isolated enzymatically were studied by patch clamp to confirm SAN identity. SAN cells (400,000) were injected into the RV subepicardial free wall and dogs were monitored for 2 weeks. Pacemaker function was assessed by overdrive pacing and IV epinephrine challenge. SAN cells expressed a time-dependent inward current (I f ) activating on hyperpolarization: density = 4.3 ± 0.6 pA/pF at −105 mV. Four of the six dogs demonstrated >50% of beats originating from the implant site at 24 h. Biological pacemaker rates on days 7-14 = 45-55 bpm and post-overdrive escape times = 1.5-2.5 s. Brisk catecholamine responsiveness occurred. Dogs implanted with autologous SAN cells manifest biological pacing properties dissimilar from those of the anatomic SAN. This highlights the importance of cell and substrate interaction in generating biological pacemaker function.
INTRODUCTION
tissues (8). Soon thereafter, implantation of fetal cells (22) or stem cells with pacemaker capability (10) was reported, as was gene delivery to modify the pacemaker Transvenous electronic pacing has been the standard for maintaining cardiac rhythm in the setting of compotential using both viral (15, 20) and mesenchymal stem cell (19) platforms. plete heart block for over 50 years (29) . Biological pacing has been explored in an effort to further optimize While proof of concept has been demonstrated for these therapies, none has achieved either the baseline pacemaker therapy (21) . One approach, autologous transplantation to the ventricle of the sinoatrial node (SAN) performance or the diversity of autonomic responsiveness characteristic of the anatomic SAN (20) . Two posor intact nodal tissue, was reported over 30 years ago, but with poor success [summarized in (16) ]. In the late sible explanations are that the biological pacemakers implanted to date were inadequately designed to assume 1990s gene delivery of the β 2 -adrenergic receptor was noted to augment the function of endogenous pacemaker the characteristics of the SAN or that the ventricular 1908 ZHANG ET AL.
myocardial substrate in which they were implanted is an The SAN cell isolation procedure invariably damages some cells and the yield of healthy cells can vary markenvironment inimical to robust expression of function of a pacemaker cell.
edly from animal to animal. Further, multiple cellular morphologies are reported to exist in both rabbit and Therefore, we tested the hypothesis that isolated, autologous SAN cells implanted into the right ventricle canine SAN (9,28) and some of these, such as so-called spider cells, can be difficult to distinguish from clusters (RV) would provide pacemaker function. We reasoned that if the approach were successful, the SAN cell might of two or more spindle cells. Thus, to ensure the highest integrity of the single cell electrophysiological data, only be a standard for developing autologous biological therapies. However, if it were inadequate, one might hypothspontaneously beating, clearly single, spindle-shaped cells were selected for biophysical study. Given the difficulty esize that the properties of the substrate-the ventricleare such that future strategies for pacemaker design of definitively identifying the number of cells within clusters, we did not attempt to quantify what fraction of would have to take the characteristics of the myocardial substrate into account more directly.
all cells met our selection criteria, but we estimate from separate experiments that more than 50% of the canine MATERIALS AND METHODS SAN cells are spindle shaped.
Intact Animal Studies
SAN cells (3-5 × 10 5 ) were injected into the right ventricle (RV) subepicardial free wall. Six-lead electroAll protocols were performed per American Physiological Society guidelines and were reviewed and apcardiography (ECG) complexes were recorded during pacing from the injection site at the time of cell adminisproved by the Institutional Animal Care and Use Committees at Columbia University and at Changhai Hospital.
tration. These provided a basis for pace-mapping comparison with the ECG complexes recorded following reSix adult male mongrel dogs (22-25 kg, Chestnut Ridge Kennels) were induced with thiopental (17 mg/kg, IV) covery from surgery. The dogs were then followed via Holter monitoring over a 2-week period as well as by and intubated. Dogs were mechanically ventilated and anesthesia was maintained with inhaled isoflurane (1.5-serial ECG recording. Function also was assessed by overdrive suppression and an IV epinephrine challenge 3.0%). Under sterile techniques percutaneous radiofrequency ablation was performed to induce complete heart at 14 days posttransplant, after which the experiment was terminated and the RV was examined for SAN cells. block and an electronic pacemaker (Discovery II, Guidant) was implanted with the pacing lead in the right Patch Clamp Studies ventricular apex and programmed at a demand rate of Patch clamp was used to confirm SAN cell identity 35 bpm. A thoracotomy was performed through the right and pacemaker function. Isolated SAN cells were placed 4th intercostal space, the sinoatrial node identified visuin a heated (35°C) bath perfused with (mM): 140 NaCl, ally and excised, and the resulting right atrial defect 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 5 HEPES, and 10 glucose closed with nonabsorbable sutures.
(pH 7.4). Single, spindle-shaped, spontaneously beating Individual SAN cells were isolated by enzymatic dicells were selected for study. Membrane potentials and gestion, as follows. The node was sectioned into 2 × 2-currents were recorded in whole cell configuration using mm pieces and incubated 30 min at 37°C in oxygenated an Axopatch-1D amplifier (Axon Instruments) with calcium-free Tyrode's solution with (in U/ml): 400 colpCLAMP software (version 8; Axon Instruments). Borolagenase (Worthington), 0.6 protease (Sigma), and 4.6 silicate glass pipettes were filled (mM): 90 aspartic acid, elastase (Worthington). The solution was replaced by a 10 NaCl, 100 CsOH, 30 CsCl, 2 MgCl 2 , 5 EGTA, 2 high K + solution(in mM: L-glutamic acid 70, KOH 80, CaCl 2 , 10 HEPES (pH 7.2). Pipette resistance was 3-5 KCl 20, β-OH-butyric acid sodium salt 10, KH 2 PO 4 10, MOhms. HEPES-KOH 10, taurine 10, albumin 1 mg/ml, pH 7.4) and triturated 3 min to dissociate cells mechanically.
Statistical Analysis The first fraction of SAN cells was isolated from the Results are expressed as means ± SD. ANOVA was supernatant.
used for statistical analysis of the ventricular rhythms Enzymatic mechanical dissociation was performed and a paired t-test was used to analyze epinephrine infutwo more times and all SAN fractions were filtered sion data. A value of p < 0.05 was considered to be sigthrough a nylon mesh under centrifugation. Calcium connificant. centration was equilibrated step-wise to 0.8 mM in Tyr-RESULTS ode's solution. SAN cells then were concentrated and Isolated SAN Cells suspended in a final volume of 1.5 ml (0.5 ml for patch clamp study, 1.0 ml for implantation). A subset was Pacemaker cells had a spindle-or spider-like shape with a single central nucleus (Fig. 1A) . Over 80% of the studied via trypan blue exclusion. cells were estimated to be viable, based on trypan blue plexes that pace-mapped to the injection site 24 h after cell administration (Fig. 3) . Summary data for these four exclusion. Eighteen cells were studied (3/dog), and had beating rates of 90 ± 17 bpm. Rhythm was stable during dogs following stabilization of rhythm are shown in Figure 2 . Note that the percent of beats pace-mapped to the the recording procedure (Fig. 1B) . The cells had a membrane capacitance of 41.6 ± 9.5 pF (n = 18) and expressed injection site declined over 14 days while the percent of electronically stimulated beats increased. Escape rates a typical time-dependent inward current (I f ) activating on hyperpolarization up to −105 mV and deactivating were over 60 bpm on day 4 and declined to 48 bpm by day 14. Escape intervals ranged from 1.5 to 3.5 s. during the following step to 15 mV (Fig. 1C) . I f density was 4.3 ± 0.6 pA/pF at −105 mV (n = 18). Summary
On day 14 animals rested quietly on the table for 30 min with their electronic pacemakers turned off. Epidata of the current-voltage relationship are shown in Figure 1D . nephrine 1.5 µg/kg/min was then infused for 10 min. The heart rates were increased by epinephrine from Intact Animal Studies 45 ± 4 to 63 ± 6 bpm (p < 0.05). Animals were then sacrificed. Disaggregated SAN cells from the myocardial Ventricular rhythms stabilized fully within 3 days after surgery and four of the six dogs showed effective implantation site were identified by microscopic examination (see Fig. 1 ) and noted to be beating spontanebiological pacing during the study period (Fig. 2) . This was evidenced as more than 50% of ventricular comously in vitro. The "Implant" ECG shows the pace-mapped surface ECG obtained by electronically pacing the implant site during surgery. ECGs were then recorded over a 14-day period. Shown are ECGs recorded on day 4, 9, and 14. Note that the QRS axis and configuration are similar to the QRS recorded during surgery suggesting the ventricular pacemaker activity is originating from the SAN cells' implant site. Paper speed = 25 mm/s; 1 cm = 1 mV. Lower panels: Escape times after overdrive pacing (A), escape rates (B), percent of electronically paced beats (C), and percent of beats that pace-mapped to the injection site (D) for the 4 dogs showing >50% of beats mapping to the injection site on days 1-2. Shown here are data from days 1, 7, and 14 as means ± SD. ANOVA shows no differences across days. See text for discussion. The similarities in function of HCN2 implanted as a source of the normal heartbeat (13). An extensive literature has since demonstrated propagation of waveforms viral construct in specialized conducting system or via a human mesenchymal stem cells (hMSC) platform in from the SA node, the action potentials of the SA node and of secondary pacemakers, and the ion currents and ventricular myocardium and SAN cells implanted in myocardium is of interest because of the very different channels responsible for primary and secondary pacemaker function (2,3,6,7,12). Paralleling discovery regardproperties of the administered pacemaker cells. Implanting HCN2 into Purkinje fibers adds a diastolic depolaring normal SA nodal function has been an appreciation of the pathology of the node and the atrioventricular izing current to a cell type that already has this current as well as the complete machinery to generate an action (AV) conducting system. A major breakthrough in masstreating AV block came about 50 years ago, and since potential. The array of Purkinje fiber ion currents includes a low I K1 ensuring that only a small hyperpolarizthen electronic pacing has been the state of the art treatment for complete heart block and a variety of other ing current will counteract the depolarizing effects of I HCN2 . In contrast, implanting hMSCs loaded with HCN2 arrhythmias (29) . Although much improved over this period and an excellent palliative electronic pacing remains into myocardium has been shown to require both the formation of functioning gap junctions among hMSCs beset by problems with lead fracture and extraction, power pack replacement, nominal autonomic responsiveand adjacent myocytes and the ability of the I HCN2 generated to counteract the hyperpolarizing effects of the roness, interference, incompatibility with the growing and developing heart, ventricular dyssynchrony, and cardiac bust I K1 of muscle (25, 26) . SAN cells have a pacemaker current initiated by failure (21, 29) .
About 10 years ago, we and others began reporting HCN4 and HCN1 and their pacemaker activity is facilitated by a low I K1 (21) . That their pacemaker function is "biological pacing," attempting to build a pacemaker via the tools of gene and cell therapy [reviewed in (21) ].
no better or worse than that of the hMSC-based pacemaker highlights the important influence of substrate on A biological pacemaker is envisioned to be of lifelong durability, autonomically responsive, implantable at pacemaker function. Among the differences between hMSC-based pacemaker cells and SAN cells are: the SA sites that will optimize cardiac output for individual patients, adaptable to growth and development, and unennode myocyte paces on its own, while the hMSC pacemaker is a two-cell functional syncytium requiring gap cumbered with risks of neoplasia, infection, interference, lead fracture, or cardiac failure (21) . Although this is a junctional coupling between hMSC and myocyte; the SA node action potential upstroke is generated by Ltall order, the availability of an electronic palliative makes the search for a biological replacement one that type calcium current whereas the hMSC pacemaker upstroke employs the sodium current of the myocyte to can seek optimization before advancement to clinical use.
In this initial decade of exploration proof of concept which it is coupled; the SA node myocyte has little or no I K1 , the hMSC-myocyte pair has more, with the I K1 has been provided using a variety of approaches to either increase inward current or decrease repolarizing current magnitude depending on myocyte properties at the placement site in the heart; the maximum diastolic poas means for creating a pacemaker potential (5,10,14,15, 17, 18, 20, 24) . Over this interval the use of variants on tential (MDP) in sinus node myocytes is roughly −60 mV; that for the myocyte component of the hMSC pacethe hyperpolarization-activated cyclic nucleotide gated (HCN) channel family of pacemaker genes has come to maker can be negative to −70 mV; the SA node employs a calcium clock as well as I f (3,12) while the role of the the fore. However, there have been significant problems as well, manifested as inadequate outcome at the level of calcium clock is uncertain in the hMSC-based pacemaker. Finally, a key determinant of primary pacemaker both biological pacemaker function and durability. For example, we have shown that implanting adult human activity is the isolation of the SA node from the atrium by limited gap junctional coupling (23,27). However the mesenchymal stem cells carrying the pacemaker gene HCN2 into the LV anterior wall of dogs with complete mechanism by which the coupling level determines primary pacemaker function is not well understood. heart block results in resting idioventricular rates of ϳ50 bpm, while adenoviral constructs of HCN2 implanted Despite numerous studies on biological pacemakers there has been little investment in understanding how into the left bundle branch region manifested basal idio- modified to take into account the substrate at the implan-
